137 related articles for article (PubMed ID: 18319568)
1. Interactions of organic anion transporters and organic cation transporters with mycotoxins.
Tachampa K; Takeda M; Khamdang S; Noshiro-Kofuji R; Tsuda M; Jariyawat S; Fukutomi T; Sophasan S; Anzai N; Endou H
J Pharmacol Sci; 2008 Mar; 106(3):435-43. PubMed ID: 18319568
[TBL] [Abstract][Full Text] [Related]
2. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs.
Khamdang S; Takeda M; Noshiro R; Narikawa S; Enomoto A; Anzai N; Piyachaturawat P; Endou H
J Pharmacol Exp Ther; 2002 Nov; 303(2):534-9. PubMed ID: 12388633
[TBL] [Abstract][Full Text] [Related]
3. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.
Kimura H; Takeda M; Narikawa S; Enomoto A; Ichida K; Endou H
J Pharmacol Exp Ther; 2002 Apr; 301(1):293-8. PubMed ID: 11907186
[TBL] [Abstract][Full Text] [Related]
4. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.
Takeda M; Khamdang S; Narikawa S; Kimura H; Kobayashi Y; Yamamoto T; Cha SH; Sekine T; Endou H
J Pharmacol Exp Ther; 2002 Mar; 300(3):918-24. PubMed ID: 11861798
[TBL] [Abstract][Full Text] [Related]
5. Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine.
Khamdang S; Takeda M; Shimoda M; Noshiro R; Narikawa S; Huang XL; Enomoto A; Piyachaturawat P; Endou H
J Pharmacol Sci; 2004 Feb; 94(2):197-202. PubMed ID: 14978359
[TBL] [Abstract][Full Text] [Related]
6. Human organic anion transporters mediate the transport of tetracycline.
Babu E; Takeda M; Narikawa S; Kobayashi Y; Yamamoto T; Cha SH; Sekine T; Sakthisekaran D; Endou H
Jpn J Pharmacol; 2002 Jan; 88(1):69-76. PubMed ID: 11855680
[TBL] [Abstract][Full Text] [Related]
7. Interactions of human organic anion transporters with diuretics.
Hasannejad H; Takeda M; Taki K; Shin HJ; Babu E; Jutabha P; Khamdang S; Aleboyeh M; Onozato ML; Tojo A; Enomoto A; Anzai N; Narikawa S; Huang XL; Niwa T; Endou H
J Pharmacol Exp Ther; 2004 Mar; 308(3):1021-9. PubMed ID: 14610216
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.
Hashimoto T; Narikawa S; Huang XL; Minematsu T; Usui T; Kamimura H; Endou H
Drug Metab Dispos; 2004 Oct; 32(10):1096-102. PubMed ID: 15377641
[TBL] [Abstract][Full Text] [Related]
9. Interactions of human organic anion transporters 1-4 and human organic cation transporters 1-3 with the stimulant drug methamphetamine and amphetamine.
Chiba S; Ro A; Ikawa T; Oide Y; Mukai T
Leg Med (Tokyo); 2020 Feb; 44():101689. PubMed ID: 32109742
[TBL] [Abstract][Full Text] [Related]
10. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
[TBL] [Abstract][Full Text] [Related]
11. Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy.
Bakhiya N; Arlt VM; Bahn A; Burckhardt G; Phillips DH; Glatt H
Toxicology; 2009 Oct; 264(1-2):74-9. PubMed ID: 19643159
[TBL] [Abstract][Full Text] [Related]
12. Interactions of human organic anion transporters with aristolochic acids.
Babu E; Takeda M; Nishida R; Noshiro-Kofuji R; Yoshida M; Ueda S; Fukutomi T; Anzai N; Endou H
J Pharmacol Sci; 2010; 113(2):192-6. PubMed ID: 20508390
[TBL] [Abstract][Full Text] [Related]
13. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors.
Enomoto A; Takeda M; Shimoda M; Narikawa S; Kobayashi Y; Kobayashi Y; Yamamoto T; Sekine T; Cha SH; Niwa T; Endou H
J Pharmacol Exp Ther; 2002 Jun; 301(3):797-802. PubMed ID: 12023506
[TBL] [Abstract][Full Text] [Related]
14. Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.
Yin J; Duan H; Shirasaka Y; Prasad B; Wang J
Drug Metab Dispos; 2015 Dec; 43(12):1872-81. PubMed ID: 26374172
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of sixteen pharmaceutical excipients on six major organic cation and anion uptake transporters.
Ma R; Li G; Wang X; Bi Y; Zhang Y
Xenobiotica; 2021 Jan; 51(1):95-104. PubMed ID: 32544367
[TBL] [Abstract][Full Text] [Related]
16. Novobiocin is a potent inhibitor for human organic anion transporters.
Duan P; You G
Drug Metab Dispos; 2009 Jun; 37(6):1203-10. PubMed ID: 19282394
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ochratoxin A transport by human organic anion transporters.
Jung KY; Takeda M; Kim DK; Tojo A; Narikawa S; Yoo BS; Hosoyamada M; Cha SH; Sekine T; Endou H
Life Sci; 2001 Sep; 69(18):2123-35. PubMed ID: 11669456
[TBL] [Abstract][Full Text] [Related]
18. Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form.
Takekuma Y; Kakiuchi H; Yamazaki K; Miyauchi S; Kikukawa T; Kamo N; Ganapathy V; Sugawara M
J Pharm Pharm Sci; 2007; 10(1):71-85. PubMed ID: 17498396
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases.
Sakurai Y; Motohashi H; Ueo H; Masuda S; Saito H; Okuda M; Mori N; Matsuura M; Doi T; Fukatsu A; Ogawa O; Inui K
Pharm Res; 2004 Jan; 21(1):61-7. PubMed ID: 14984259
[TBL] [Abstract][Full Text] [Related]
20. Subchronic exposure to individual and combined ochratoxin A and citrinin affects the expression of rat renal organic anion transporters.
Karaica D; Micek V; Rašić D; Peraica M; Šegvić Klarić M; Breljak D
Mycotoxin Res; 2020 Nov; 36(4):339-352. PubMed ID: 32653990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
